2023-2024 Regular Session • California Legislature
AB2942: Novel Allogeneic Adipose Cell-Based Viral Therapies Clinical Trials Grant Program.
Legislative Summary
An act to add and repeal Article 5 (commencing with Section 104211) of Chapter 2 of Part 1 of Division 103 of the Health and Safety Code, relating to public health.
Demographic Impact
Overall analysis of equity impact
70% Positive
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/15/2024
Read first time. To print.
State Assembly
2/16/2024
From printer. May be heard in committee March 17.
State Assembly
3/21/2024
Referred to Com. on HEALTH.
State Assembly
3/21/2024
From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.
State Assembly
4/1/2024
Re-referred to Com. on HEALTH.
State Assembly
4/24/2024
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 16. Noes 0.) (April 23).
State Assembly
4/25/2024
Read second time and amended.
State Assembly
4/29/2024
Re-referred to Com. on APPR.
State Assembly
5/15/2024
In committee: Set, first hearing. Referred to APPR. suspense file.
State Assembly
5/16/2024
Joint Rule 62(a), file notice suspended. (Page 5215.)
State Assembly
5/16/2024
In committee: Held under submission.
State Assembly
Roll Call Votes
Do pass as amended and be re-referred to the Committee on [Appropriations]
4/23/2024
16
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Introduced(2/15/2024)
Chamber
State Assembly
Sine DiePrior Session
